Julian S. Gangolli - Insider Trading & Ownership

Entity
Individual
Location
4955 Baseline Avenue, Santa Ynez, California
Summary
The estimated net worth of Julian S. Gangolli is at least $581 K dollars as of July 1, 2024. Julian S. Gangolli is the Director of Krystal Biotech, Inc. and owns shares of Krystal Biotech, Inc. (KRYS) stock worth about $410 K. Julian S. Gangolli is the Director of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $172 K.
All Insider Reports
All Insider Reports

Ownership of Julian S. Gangolli

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KRYS Krystal Biotech, Inc. Director $410 K -$3.28 M -88.9% Jun 30, 2024
RVNC Revance Therapeutics, Inc. Director $172 K May 1, 2024
OTLK Outlook Therapeutics, Inc. Director Mar 7, 2024

Insider Transactions Reported by Julian S. Gangolli:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership